ERBB2 and neoplasm: Univariable logistic regression analysis showed that patients with no cardiometabolic comorbidities were significantly associated with favourable pathological features including smaller tumours (<2 cm), no nodal involvement and also absence of distance metastasis or HER2 overexpression, compared to their counterparts with two or more (clustering) cardiometabolic comorbidities (results not shown).